Policy library / J3393 Commercial payer policies listing J3393 6 policies from 6 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Anthem policies listing J3393, with the code’s status in each Policy Effective Status of J3393 Gene Therapy for Beta Thalassemia PayerPolicy · ANTHEM-MED.00140 Jan 30, 2025 Covered
BCBS Illinois policies listing J3393, with the code’s status in each Policy Effective Status of J3393 Gene Therapies for Thalassemia PayerPolicy · BCBSIL-RX501.166 Sep 1, 2026 Covered
BCBS Montana policies listing J3393, with the code’s status in each Policy Effective Status of J3393 Gene Therapies for Thalassemia PayerPolicy · BCBSMT-RX501.166 Sep 1, 2026 Covered
BCBS New Mexico policies listing J3393, with the code’s status in each Policy Effective Status of J3393 Gene Therapies for Thalassemia PayerPolicy · BCBSNM-RX501.166 Sep 1, 2026 Covered
BCBS Oklahoma policies listing J3393, with the code’s status in each Policy Effective Status of J3393 Gene Therapies for Thalassemia PayerPolicy · BCBSOK-RX501.166 Sep 1, 2026 Covered
Humana policies listing J3393, with the code’s status in each Policy Effective Status of J3393 Gene Therapy Treatments for Beta Thalassemia PayerPolicy · HUMANA-GENE-THERAPY-TREATMENTS-FOR-BETA-THALASSEMIA-MA Dec 1, 2025 Covered